Connect Biopharma Limite... (CNTB)
NASDAQ: CNTB
· Real-Time Price · USD
1.63
-0.18 (-9.94%)
At close: Aug 20, 2025, 10:05 AM
Connect Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 48K | 1.91M | 24.12M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 183.53K | n/a | 481.87K | 506.13K | 527.3K | 503.34K | 412.05K | 221.39K |
Gross Profit | 48K | 1.73M | 23.64M | -481.87K | -506.13K | -527.3K | -503.34K | -412.05K | -221.39K |
Operating Income | -13.42M | -24.91M | 7.31M | -27.23M | -34.84M | -54.28M | -63.38M | -58.26M | -41.09M |
Interest Income | 619K | 4.03M | 822K | -2.49M | 2.49M | 1.29M | 271.1K | 54.89 | 22.92 |
Pretax Income | -12.84M | -23.05M | 7.71M | -28.87M | -30.52M | -56.49M | -59.63M | -56.39M | -145.71M |
Net Income | -12.9M | -23.22M | 7.65M | -28.92M | -30.58M | -56.68M | -59.74M | -56.65M | -145.71M |
Selling & General & Admin | 4.7M | 11.8M | 7.43M | 5.92M | 7.61M | 9.16M | 11.21M | 11.17M | 7.19M |
Research & Development | 8.77M | 15.9M | 13.32M | 25.18M | 26.73M | 44.6M | 50.66M | 46.68M | 33.67M |
Other Expenses | n/a | -1.07M | -3.94M | -4.35M | n/a | n/a | -940.31K | n/a | n/a |
Operating Expenses | 13.47M | 26.63M | 16.81M | 27.74M | 34.34M | 53.76M | 60.93M | 57.85M | 40.87M |
Interest Expense | n/a | -20K | 20K | -10.39K | 10.39K | 12.32K | 8.72K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 5.94M | 7.58M | 9.12M | -9.12M | 11.16M | 7.19M |
Cost & Expenses | 13.47M | 26.82M | 16.81M | 27.23M | 34.84M | 54.28M | 60.4M | 58.26M | 41.09M |
Income Tax Expense | 55K | 162.58K | 60K | 55.22K | 64.78K | 186.17K | 111.34K | 263.87K | n/a |
Shares Outstanding (Basic) | 55.5M | 55.19M | 55.14M | 55.07M | 55.05M | 55.02M | 55.02M | 53.74M | 46.94M |
Shares Outstanding (Diluted) | 55.5M | 55.19M | 55.55M | 55.07M | 55.05M | 55.02M | 55.02M | 53.74M | 46.94M |
EPS (Basic) | -0.23 | -0.42 | 0.14 | -0.52 | -0.56 | -1.03 | -13.47 | -1.05 | -3.1 |
EPS (Diluted) | -0.23 | -0.42 | 0.14 | -0.52 | -0.56 | -1.03 | -13.47 | -1.05 | -3.1 |
EBITDA | -13.25M | -22.87M | 8.2M | -28.37M | -30M | -53.76M | -57.55M | -57.85M | -40.87M |
EBIT | -13.42M | -23.05M | 7.72M | -28.85M | -30.51M | -56.48M | -61.56M | -56.39M | -20.58M |
Depreciation & Amortization | 171K | 183.53K | 476K | 481.87K | 506.13K | 527.3K | 486.34K | 412.05K | 221.39K |